Status:
COMPLETED
In Hospital Course of Acute Coronary Artery Syndromes
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Acute Coronary Syndrome
Intensive Care Unit Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
While international guidelines have indicated that use of a routine invasive strategy was favored for high-risk patients with NSTE-ACS and for all STE- ACS, the lower risk patients successfully reperf...
Detailed Description
All patients admitted in the ICU Montpellier University center for ACS from May 2019 to May 2020 will be evaluated and classed as low risk patients (groupe LR) or not low risk patients (NLR) after cor...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- ACS with or without ST elevation during the inclusion period (May 2019 to May 2020)
- Patients all admitted in ICU after coronary angiography and angioplasty if required
- Exclusion criteria:
- Patients not admitted in ICU
- Patients without coronary angiography evaluation
- lack of patient consent
Exclusion
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
269 Patients enrolled
Trial Details
Trial ID
NCT04378504
Start Date
May 1 2019
End Date
July 1 2020
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295